0001671284false00016712842021-08-022021-08-02


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934

Date of Report (date of earliest event reported): August 2, 2021

Bright Health Group, Inc.
(Exact name of registrant as specified in its charter)
Delaware
001-40537
47-4991296
(State or other jurisdiction of incorporation or organization)
(Commission File Number)
(I.R.S. Employer Identification No.)
8000 Norman Center Drive Suite 1200, Minneapolis, Minnesota
55437
Address of Principal Executive Office (Zip Code)
(612) 238-1321
Registrant's telephone number, including area code

Not Applicable
(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $0.0001 par value per share BHG New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
o


Item 1.01     Entry into a Material Definitive Agreement.

On August 2, 2021, Bright Health Group, Inc. (the "Company"), entered into Amendment No. 1 (the “Amendment”) to its Credit Agreement, dated March 1, 2021, among the Company, the other Loan Parties party thereto, the Lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent (as amended by the Amendment, the “Credit Agreement”).

The Amendment changed the definition of “Qualified IPO” in Section 1.1. of the Credit Agreement by reducing the net proceeds required to be received by the Company from $1,000,000,000 to $850,000,000. In addition, prior to the Amendment, the Credit Agreement contained a covenant that required the Company to maintain a total debt to capitalization ratio of (a) 0.25 to 1.00 prior to a Qualified IPO, and (b) 0.30 to 1.00 after a Qualified IPO. The Amendment changed this covenant by removing the increase in the ratio after a Qualified IPO such that the Company is now required to maintain a total debt to capitalization ratio of 0.25 to 1.00.

The above summary of the Amendment is qualified in its entirety by reference to the full and complete terms of the Amendment which is included as Exhibit 10.1 to this Current Report on Form 8-K and incorporated herein by reference, and to the full and complete terms of the Credit Agreement, which was included as an exhibit to the Company’s Registration Statement on Form S-1 filed with the Securities and Exchange Commission on June 15, 2021.

Item 2.03     Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

The information set forth in Item 1.01 is incorporated herein by reference into Item 2.03.

Item 8.01     Other Events.

On August 4, 2021, the Company delivered a notice of election to the administrative agent and each lender under the Credit Agreement to extend the maturity date of the Credit Agreement from February 28, 2022 to February 28, 2024.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.
Exhibit
No. 		Description
10.1
104 The cover page from the Current Report on Form 8-K formatted in Inline XBRL.



SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

BRIGHT HEALTH GROUP, INC.
Date: August 6, 2021 By: /s/ Keith Nelsen
Name: Keith Nelsen
Title: General Counsel and Corporate Secretary







Exhibit 10.1

[EXECUTION VERSION]


AMENDMENT NO. 1 dated as of August 2, 2021 (this “Amendment”), among BRIGHT HEALTH GROUP, INC. (the “Company”), the other LOAN PARTIES party hereto, the LENDERS party hereto and JPMORGAN CHASE BANK, N.A., in its capacity as administrative agent (the “Administrative Agent”).

Reference is made to the Credit Agreement dated as of March 1, 2021 (as amended, supplemented or otherwise modified from time to time prior to the date hereof, the “Credit Agreement”), among the Company, the Lenders party thereto and the Administrative Agent. Capitalized terms used and not otherwise defined herein shall have the meanings assigned to them in the Credit Agreement.

The Company has requested, and the Administrative Agent and the Lenders party hereto agree, in accordance with Section 15.1 of the Credit Agreement, to amend the Credit Agreement on the terms and subject to the conditions set forth herein.

NOW, THEREFORE, in consideration of the premises and covenants contained herein and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, intending to be legally bound hereby, agree as follows:

Section 1. Amendment. Subject to the satisfaction of the conditions precedent set forth in Section 3 hereof:

(a)the defined term “Qualified IPO” in Section 1.1 of the Credit Agreement is hereby amended by replacing the text “$1,000,000,000” with the text “$850,000,000”; and

(b)Section 11.12.1 of the Credit Agreement is hereby amended in its entirety to read as follows:

“Not permit the Total Debt to Total Capitalization Ratio as of the last day of each Computation Period, beginning with the Computation Period ending June 30, 2021, to exceed 0.25 to 1.00.”.

Section 2. Representations and Warranties. The Company represents and warrants that as of the date hereof and the Amendment Effective Date:

(a)After giving effect to this Amendment, the representations and warranties contained in Section 9 of the Credit Agreement are true and correct (i) in the case of the representations and warranties qualified as to materiality, in all respects and (ii) otherwise, in all material respects; except in the case of any such representation and warranty that expressly relates to a prior date, in which case such representation and warranty shall be so true and correct on and as of such prior date.

(b)After giving effect to this Amendment, no Default or Event of Default has occurred and is continuing.


Section 3.    Conditions to Effectiveness.

This Amendment shall become effective on the first date (the “Amendment Effective Date”) on which the Administrative Agent shall have received (a) a certificate, dated the Amendment Effective Date and signed by a Responsible Officer of the Company, confirming that the representations and warranties set forth in Section 2 hereof are true and correct in all respects, and (b) executed counterparts of this Amendment by (i) the Company, (ii) each of the other Loan Parties, (iii) the Administrative Agent and (iv) the requisite Lenders.

The Administrative Agent shall notify the Company and the Lenders of the Amendment Effective Date and such notice shall be conclusive and binding.

Section 4.    Fees and Expenses.

The Company agrees to reimburse the Administrative Agent for its reasonable and documented out-of-pocket expenses incurred by it in connection with this Amendment, including the reasonable fees, charges and disbursements of Cravath, Swaine & Moore LLP, counsel for the Administrative Agent.

Section 5.    Counterparts.

This Amendment may be executed in any number of counterparts and by different parties hereto in separate counterparts, each of which when so executed shall be deemed to be an original and all of which taken together shall constitute one and the same agreement. The words “execution”, “signed”, “signature”, “delivery”, and words of like import in or relating to this Amendment and/or any document to be signed in connection with this Amendment and the transactions contemplated hereby shall be deemed to include Electronic Signatures, deliveries or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or enforceability as a manually executed signature, physical delivery thereof or the use of a paper- based recordkeeping system, as the case may be.

Section 6.    Reaffirmation by Loan Parties.

Each of the Loan Parties, as debtor, grantor, pledgor, guarantor, assignor, or in any other similar capacity in which such Loan Party grants liens or security interests in its property or acts as a guarantor, hereby (a) ratifies and reaffirms all of its payment and performance obligations, contingent or otherwise, under each of the Loan Documents to which it is a party (after giving effect hereto) and (b) to the extent such Loan Party granted liens on or security interests in any of its property pursuant to any such Loan Document as security for, or guaranteed, the Obligations under the Loan Documents, ratifies and reaffirms such grant of security interests and liens and such guarantee and confirms and agrees that such security interests and liens hereafter secure all of the Obligations as amended hereby.
Section 7. Governing Law; Amendment of Right to Trial by Jury, Etc. THIS AMENDMENT AND ANY CLAIM, CONTROVERSY, DISPUTE OR
CAUSE OF ACTION ARISING UNDER OR RELATED TO THIS AMENDMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE SUBSTANTIVE


LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CHOICE OF LAW
DOCTRINES. The provisions of Sections 15.4, 15.6, 15.7, 15.15, 15.20 and 15.24 of the Credit Agreement are hereby incorporated by reference as if set forth in full herein, mutatis mutandis.

Section 8.    Headings.

The headings of this Amendment are for purposes of reference only and shall not be deemed to limit, amplify or modify the terms of this Amendment, nor affect the meaning hereof.

Section 9.    Effect of Amendment; References to the Credit Agreement.

Except as expressly set forth herein, this Amendment shall not by implication or otherwise limit, impair, constitute a waiver of or otherwise affect the rights and remedies of the Administrative Agent, any Lender or any Issuing Bank under the Credit Agreement or any agreement or document relating thereto, and except as expressly provided in this Amendment, shall not alter, modify, amend or in any way affect any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any such other agreement or document, all of which are ratified and affirmed in all respects and shall continue in full force and effect. This Amendment shall constitute a Loan Document for all purposes of the Credit Agreement and the other Loan Documents. On and after the Amendment Effective Date, each reference in the Credit Agreement to “this Agreement”, “hereunder”, “hereof” or words of like import referring to the Credit Agreement shall mean and be a reference to the Credit Agreement as amended hereby. Nothing herein shall entitle the Company to a consent to, or a waiver, extension, amendment, modification or other change of, any of the terms, conditions, obligations, covenants or agreements contained in the Credit Agreement or any agreement or document relating thereto in any similar or different circumstances.

[REMAINDER OF PAGE LEFT INTENTIONALLY BLANK]


IN WITNESS WHEREOF, the parties hereto have caused this Amendment to be duly executed as of the date first above written.


BRIGHT HEALTH GROUP, INC.,
as the Company

By: /s/ Cathy Smith
Name: Cathy Smith
Title:
Executive Vice President and Chief Financial Officer and Chief Administrative Officer

BRIGHT HEALTH MANAGEMENT, INC.
BRIGHT HEALTH SERVICES, INC.
MEDICAL PRACTICE HOLDING
COMPANY, LLC
BRIGHTHEALTH NETWORKS, LLC PHYSICIANS PLUS ACO, LLC
PINEAPPLE ACO, LLC
PHYSICIANS PLUS, LLC
PHYSICIANS PLUS OF FLORIDA, LLC PHYSICIANS PLUS OF CALIFORNIA, LLC NEUEHEALTH LLC,
as Guarantors


By: /s/ Cathy Smith
Name: Cathy Smith
Title:
Chief Financial Officer



JPMORGAN CHASE BANK, N.A.,
as Administrative Agent and Lender

By: /s/ Dawn Lee Lum
Name: Dawn Lee Lum
Title:
Executive Director


















































[Signature Page to Amendment No. 1 to Credit Agreement]


BARCLAYS BANK PLC
as Lender

By: /s/ Arvind Admal
Name: Arvind Admal
Title:
Vice President




























[Signature Page to Amendment No. I to Credit Agreement]


GOLDMAN SACHS LENDING PARTNERS LLC,
as Lender

By: /s/ Dan Martis
Name: Dan Martis
Title:
Authorized Signatory






































[Signature Page to Amendment No. I to Credit Agreement]


MORGAN STANLEY SENIOR FUNDING, INC.,
as Lender

By: /s/ Jake Dowden
Name: Jake Dowden
Title:
Authorized Signatory






































[Signature Page to Amendment No. I to Credit Agreement]


BANK OF AMERICA, N.A.,
as Lender

By: /s/ Joseph L. Corah
Name: Joseph L. Corah
Title:
Director






































[Signature Page to Amendment No. I to Credit Agreement]